AAAAAA

   
Results: 1-17 |
Results: 17
COMPARING OUTCOMES IN RENAL REPLACEMENT THERAPY - HOW SHOULD WE CORRECT FOR CASE-MIX (VOL 31, PG 473, 1998)
Authors: KHAN IH CAMPBELL MK CANTAROVICH D CATTO GRD DELCROIX C EDWARD N FONTENAILLE C VANHAMERSVELT HW HENDERSON IS KOENE RAP PAPADIMITRIOU M RITZ E RAMSAY C TSAKIRIS D MACLEOD AM
Citation: Ih. Khan et al., COMPARING OUTCOMES IN RENAL REPLACEMENT THERAPY - HOW SHOULD WE CORRECT FOR CASE-MIX (VOL 31, PG 473, 1998), American journal of kidney diseases, 31(5), 1998, pp. 900-900
COMPARING OUTCOMES IN RENAL REPLACEMENT THERAPY - HOW SHOULD WE CORRECT FOR CASE-MIX
Authors: KHAN IH CAMPBELL MK CATAROVICH D CATTO GRD DELCROIX C EDWARD N FONTENAILLE C VANHAMERSVELT HW HENDERSON IS KOENE RAP PAPADIMITRIOU M RITZ E RAMSAY C TSAKIRIS D MACLEOD AM
Citation: Ih. Khan et al., COMPARING OUTCOMES IN RENAL REPLACEMENT THERAPY - HOW SHOULD WE CORRECT FOR CASE-MIX, American journal of kidney diseases, 31(3), 1998, pp. 473-478
REDUCED SHELF-LIFE OF RENALIN PROCESSED DIALYZERS
Authors: LAFFERTY ME FOULIS JA PERRY M MCGREGOR E HENDERSON IS JONES MC
Citation: Me. Lafferty et al., REDUCED SHELF-LIFE OF RENALIN PROCESSED DIALYZERS, Journal of the American Society of Nephrology, 8, 1997, pp. 773-773
FACTORS WHICH INFLUENCE ONE-YEAR GRAFT-SURVIVAL IN A SMALL TRANSPLANTCENTER
Authors: BROVIG KM LAFFERTY ME MCGREGO E HENDERSON IS JONES MC
Citation: Km. Brovig et al., FACTORS WHICH INFLUENCE ONE-YEAR GRAFT-SURVIVAL IN A SMALL TRANSPLANTCENTER, Journal of the American Society of Nephrology, 8, 1997, pp. 3147-3147
HOMOCYSTEINE AND CHOLESTEROL LEVELS IN CYCLOSPORINE-TREATED AND AZATHIOPRINE-TREATED RENAL-TRANSPLANT PATIENTS
Authors: LAFFERTY ME STRACHAN J MCGREGOR E HENDERSON IS JONES MC
Citation: Me. Lafferty et al., HOMOCYSTEINE AND CHOLESTEROL LEVELS IN CYCLOSPORINE-TREATED AND AZATHIOPRINE-TREATED RENAL-TRANSPLANT PATIENTS, Kidney international, 52(4), 1997, pp. 1132-1132
TREATMENT OF SEVERE ACUTE VASCULAR REJECTION IN A RENAL-ALLOGRAFT WITH MYCOPHENOLATE MOFETIL AND HIGH-DOSE STEROIDS
Authors: LAFFERTY ME LANG S MCGREGOR E HENDERSON IS JONES MC
Citation: Me. Lafferty et al., TREATMENT OF SEVERE ACUTE VASCULAR REJECTION IN A RENAL-ALLOGRAFT WITH MYCOPHENOLATE MOFETIL AND HIGH-DOSE STEROIDS, Scottish Medical Journal, 42(3), 1997, pp. 79-80
THE EFFECT OF CEFODIZIME ON PHAGOCYTE FUNCTION IN NONPATIENT VOLUNTEERS AND PATIENTS WITH CHRONIC-RENAL-FAILURE - IN-VITRO AND EX-VIVO STUDIES
Authors: MCCAFFERTY AC MCGREGOR E JONES M HENDERSON IS CREE IA
Citation: Ac. Mccafferty et al., THE EFFECT OF CEFODIZIME ON PHAGOCYTE FUNCTION IN NONPATIENT VOLUNTEERS AND PATIENTS WITH CHRONIC-RENAL-FAILURE - IN-VITRO AND EX-VIVO STUDIES, International journal of clinical & laboratory research, 26(4), 1996, pp. 229-235
SURVIVAL ON RENAL REPLACEMENT THERAPY IN EUROPE - IS THERE A CENTER EFFECT
Authors: KHAN IH CAMPBELL MK CANTAROVICH D CATTO GRD DELCROIX C EDWARD N FONTENAILLE C FLEMING LW GERLAG PGG VANHAMERSVELT HW HENDERSON IS KOENE RAP PAPADIMITRIOU M RITZ E RUSSELL IT STIER E TSAKIRIS D MACLEOD AM
Citation: Ih. Khan et al., SURVIVAL ON RENAL REPLACEMENT THERAPY IN EUROPE - IS THERE A CENTER EFFECT, Nephrology, dialysis, transplantation, 11(2), 1996, pp. 300-307
PERIPHERAL MICROCIRCULATORY BLOOD-FLOW IN HEMODIALYSIS-PATIENTS TREATED WITH ERYTHROPOIETIN
Authors: TAYLOR JE BELCH JJF HENDERSON IS STEWART WK
Citation: Je. Taylor et al., PERIPHERAL MICROCIRCULATORY BLOOD-FLOW IN HEMODIALYSIS-PATIENTS TREATED WITH ERYTHROPOIETIN, International angiology, 15(1), 1996, pp. 33-38
ACQUIRED PERFORATING DERMATOSIS IN A BRITISH DIALYSIS POPULATION
Authors: MORTON CA HENDERSON IS JONES MC LOWE JG
Citation: Ca. Morton et al., ACQUIRED PERFORATING DERMATOSIS IN A BRITISH DIALYSIS POPULATION, British journal of dermatology, 135(5), 1996, pp. 671-677
CALCIUM ACETATE VERSUS CALCIUM-CARBONATE AS PHOSPHATE-BINDING AGENTS IN CHRONIC-HEMODIALYSIS
Authors: PFLANZ S HENDERSON IS MCELDUFF N JONES MC
Citation: S. Pflanz et al., CALCIUM ACETATE VERSUS CALCIUM-CARBONATE AS PHOSPHATE-BINDING AGENTS IN CHRONIC-HEMODIALYSIS, Nephrology, dialysis, transplantation, 9(8), 1994, pp. 1121-1124
ERYTHROPOIETIN DOES NOT INCREASE WHOLE-BLOOD PLATELET-AGGREGATION IN-VITRO
Authors: TAYLOR JE BELCH JJF HENDERSON IS STEWART WK
Citation: Je. Taylor et al., ERYTHROPOIETIN DOES NOT INCREASE WHOLE-BLOOD PLATELET-AGGREGATION IN-VITRO, Nephrology, dialysis, transplantation, 9(5), 1994, pp. 556-558
ERYTHROPOIETIN RESPONSE AND ROUTE OF ADMINISTRATION
Authors: TAYLOR JE BELCH JJF FLEMING LW MACTIER RA HENDERSON IS STEWART WK
Citation: Je. Taylor et al., ERYTHROPOIETIN RESPONSE AND ROUTE OF ADMINISTRATION, Clinical nephrology, 41(5), 1994, pp. 297-302
WOUND AND PERINEPHRIC HEMATOMAS INFECTION WITH MYCOPLASMA-HOMINIS IN A RENAL-TRANSPLANT RECIPIENT
Authors: ORANGE GV JONES M HENDERSON IS
Citation: Gv. Orange et al., WOUND AND PERINEPHRIC HEMATOMAS INFECTION WITH MYCOPLASMA-HOMINIS IN A RENAL-TRANSPLANT RECIPIENT, Nephrology, dialysis, transplantation, 8(12), 1993, pp. 1395-1396
ERYTHROPOIETIN DOES NOT INCREASE WHOLE-BLOOD PLATELET-AGGREGATION IN-VITRO
Authors: TAYLOR JE BELCH JJF HENDERSON IS STEWART WK
Citation: Je. Taylor et al., ERYTHROPOIETIN DOES NOT INCREASE WHOLE-BLOOD PLATELET-AGGREGATION IN-VITRO, Nephrology, dialysis, transplantation, 8(11), 1993, pp. 1291-1293
EFFECT OF ERYTHROPOIETIN THERAPY AND WITHDRAWAL ON BLOOD-COAGULATION AND FIBRINOLYSIS IN HEMODIALYSIS-PATIENTS
Authors: TAYLOR JE BELCH JJF MCLAREN M HENDERSON IS STEWART WK
Citation: Je. Taylor et al., EFFECT OF ERYTHROPOIETIN THERAPY AND WITHDRAWAL ON BLOOD-COAGULATION AND FIBRINOLYSIS IN HEMODIALYSIS-PATIENTS, Kidney international, 44(1), 1993, pp. 182-190
PROTHROMBOTIC EFFECT OF ERYTHROPOIETIN IN DIALYSIS PATIENTS
Authors: TAYLOR JE MCLAREN M HENDERSON IS BELCH JJF STEWART WK
Citation: Je. Taylor et al., PROTHROMBOTIC EFFECT OF ERYTHROPOIETIN IN DIALYSIS PATIENTS, Nephrology, dialysis, transplantation, 7(3), 1992, pp. 235-239
Risultati: 1-17 |